New shot for eczema shows promise in large trial
NCT ID NCT06468956
First seen Oct 01, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This study tests an experimental injection called SHR-1819 for adults with moderate to severe atopic dermatitis (eczema). The goal is to see if it can clear skin rashes and reduce itching better than a placebo. 652 participants are taking part in this Phase 3 trial, which is the final stage before seeking approval.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Fudan University HuaShan Hospital
Shanghai, Shanghai Municipality, 200040, China
Conditions
Explore the condition pages connected to this study.